Edible vaccines mark a groundbreaking approach to immunization by harnessing plant-based resources for vaccine development. Unlike conventional injections, these vaccines are ingested through genetically modified plants. This innovative strategy aims to improve accessibility, lower costs, and streamline vaccine distribution, particularly in regions with limited resources. The edible vaccine process involves introducing a specific gene into the plant's genetic code, enabling it to produce a vaccine protein. The potential of administering vaccines orally eliminates the necessity for injections, offering a more convenient and less invasive method of immunization. Edible vaccines present notable advantages, including heightened stability, simplified transportation, and reduced reliance on cold storage. Moreover, they hold the potential to overcome challenges associated with needle-based vaccination, fostering greater acceptance and participation in immunization initiatives. Ongoing research and development in this field may herald a transformative shift in global vaccination strategies, addressing health disparities and promoting extensive immunization coverage.
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Recombinant BCG vaccine as a potent anti tuberculosis vaccine candidate
Sajal Dey, BRIC-Centre for DNA Fingerprinting and Diagnostics, India
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : From local pilots to national policy: Key issues and challenges in implementing nationwide HPV vaccination in China
Shenglan Tang, Duke Global Health Institute, United States